Joint Corp Q3 net loss $3.2M; guides down system-wide sales and new openings

JOINT Corp

2024-Q3 EPS reported -$0.39 revenue$90,181,217

Revenue $30.2M (+2% YoY); net loss $3.2M vs $716K loss in Q3 2023, including $3.8M impairment.
Adjusted EBITDA fell to $2.4M from $2.9M; system-wide sales up 18% to $129.3M.
Guidance cut: system-wide sales now $525-535M (prior $530-545M); new franchised openings 55-60 (prior 60-75).
Total clinics 963 at Sept 30; sold 7 franchise licenses in Q3 vs 12 in Q3 2023.
Unrestricted cash $20.7M; $20M credit facility available through Feb 2027.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.